Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.72 |
| ▸ | TSHR | P16473 | 3/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | ATM | Q13315 | 1/20 | 0.72 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MMP14 | P50281 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5147120 | 0.86 | CYP3A4 (0.78) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL2215691 | 0.85 | CYP3A4 (0.77) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL44320 | 0.85 | CYP3A4 (0.89) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL1155390 | 0.85 | CYP3A4 (0.77) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL11249590 | 0.85 | CYP3A4 (0.81) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL6790739 | 0.85 | TSHR (0.48) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL3849332 | 0.84 | CYP3A4 (0.93) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL27423 | 0.84 | CYP3A4 (1.00) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL1336595 | 0.84 | CYP3A4 (0.86) | CYP3A4TSHRTDP1ATMRECQL | |
| SCHEMBL6014128 | 0.84 | CYP3A4 (0.86) | CYP3A4TSHRTDP1ATMRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2159227-B1 | Two-photon absorption material and application thereof | RICOH CO LTD (JP) | 2014-08-06 | — | — | EP | claimed |
| US-7683218-B2 | Method for producing thioether compound | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2010-03-23 | — | — | US | claimed |
| US-20080108823-A1 | Method For Producing Thioether Compound | MSD K.K. (JP) | 2008-05-08 | — | — | US | claimed |
| EP-1806337-A1 | METHOD FOR PRODUCING THIOETHER COMPOUND | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-07-11 | — | — | EP | claimed |
| US-5362707-A | Oil and either /A/ nonionic or anionic surfactant, or /B/ second surfactant with sucroglycerides and alkoxylated fatty acid or triglyceride, sorbitan ester or alkoxylated sorbitan ester; solid, water-insoluble plant-protection substance | RHONE-POULENC CHIMIE (FR) | 1994-11-08 | — | — | US | claimed |
| US-4960873-A | 3-pyridylisothiazoleazo compounds useful as disperse dyes | BASF AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | claimed |
| EP-4279565-A2 | THIOPHENE COMPOUND, LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | Merck Patent GmbH (DE) | 2023-11-22 | — | — | EP | disclosed |
| CN-109554181-B | Liquid crystal medium and liquid crystal display comprising same | 默克专利股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-3877484-B1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | MERCK PATENT GMBH (DE) | 2023-09-13 | — | — | EP | disclosed |
| EP-3763802-B1 | THIOPHENE COMPOUND, LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | MERCK PATENT GMBH (DE) | 2023-09-06 | — | — | EP | disclosed |
| CN-109207161-B | Liquid crystal medium and liquid crystal display comprising same | 默克专利股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| US-20230045269-A1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME | MERCK PATENT GMBH (DE) | 2023-02-09 | — | — | US | disclosed |
| US-11168255-B2 | Thiophene compound, liquid-crystalline medium and liquid-crystal display comprising the same | MERCK PATENT GMBH (DE) | 2021-11-09 | — | — | US | disclosed |
| EP-0441396-A1 | Thermal transfer recording sheet and ink composition for producing the same | MITSUBISHI KASEI CORPORATION (JP) | 1991-08-14 | — | — | EP | disclosed |
| US-4960873-A | 3-pyridylisothiazoleazo compounds useful as disperse dyes | BASF AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | disclosed |
| EP-0344487-A2 | Azo dyes of the 5-aminoisothiazole series | BASF Aktiengesellschaft (DE) | 1989-12-06 | — | — | EP | disclosed |
| EP-0335234-A2 | Azo isoathiazole dyes | BASF Aktiengesellschaft (DE) | 1989-10-04 | — | — | EP | disclosed |
| US-4844733-A | PRE- AND POSTEMERGENCE | BASF AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | disclosed |
| EP-0236916-A2 | N-aryltetrahydrophthalimide derivatives and their precursors | BASF Aktiengesellschaft (DE) | 1987-09-16 | — | — | EP | disclosed |
| US-4229345-A | (2-Chloro-4-cyanophenyl) (4-dialkylaminophenyl)-diazine dye useful for transfer printing | BASF AKTIENGESELLSCHAFT (DE) | 1980-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108823-A1 | Method For Producing Thioether Compound | TST, MPST, PPIP5K2 | CYP3A4 1947/4885TSHR 122/4885TDP1 3155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.